Evidence map›Paper›PMID 39003520›Full record

ArticleJournal of the National Cancer Institute2024

The utility of value frameworks in cost communications: making them real for patients.

Ya-Chen Tina Shih, K Robin Yabroff, Cathy Bradley

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ya-Chen Tina ShihUniversity of California Los Angeles Jonsson Comprehensive Cancer Center and Department of Radiation Oncology, School of Medicine, Los Angeles, CA, USA.ORCID 0000-0001-7290-3864
K Robin YabroffDepartment of Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.
Cathy BradleyUniversity of Colorado Comprehensive Cancer Center and Department of Health Systems, Management & Policy, Colorado School of Public Health, Aurora, CO, USA.ORCID 0000-0001-9429-6567

Funding

Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors, and Economic ImplicationsR01CA225647 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHIH, YA-CHEN TINA · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA225647NCI NIH HHS R01CA225647
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CommunicationCost-Benefit AnalysisHealth Care CostsHumansNeoplasms

Identifiers

PMID39003520
PMCPMC11378310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.